| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cartesian Therapeutics, Inc. | Chief Medical Officer | Common Stock | 35,393 | $595,742 | $16.83 | 06 Jan 2025 | Direct |
| Cartesian Therapeutics, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 30,528 | $24,117 | $0.7900 | 15 Nov 2024 | Direct |
| Cartesian Therapeutics, Inc. | Chief Medical Officer | Employee Stock Option (right to buy) | 56,000 | 02 Jan 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RNAC | Cartesian Therapeutics, Inc. | 03 Jan 2025 | 2 | -$31,542 | 4 | Chief Medical Officer | 07 Jan 2025, 20:05 |
| RNAC | Cartesian Therapeutics, Inc. | 02 Jan 2025 | 2 | $0 | 4 | Chief Medical Officer | 06 Jan 2025, 16:20 |
| RNAC | Cartesian Therapeutics, Inc. | 14 Nov 2024 | 6 | -$729,882 | 4 | Chief Medical Officer | 18 Nov 2024, 19:28 |
| RNAC | Cartesian Therapeutics, Inc. | 08 Apr 2024 | 2 | $0 | 4 | Chief Medical Officer | 10 Apr 2024, 21:33 |
| RNAC | Cartesian Therapeutics, Inc. | 02 Jan 2024 | 2 | $0 | 4 | Chief Medical Officer | 04 Jan 2024, 17:06 |
| SELB | Cartesian Therapeutics, Inc. | 13 Nov 2023 | 1 | $0 | 4 | Chief Medical Officer | 15 Nov 2023, 16:40 |
| SELB | Cartesian Therapeutics, Inc. | 13 Nov 2023 | 0 | $0 | 3 | Chief Medical Officer | 15 Nov 2023, 16:37 |